Erlocip 150 mg Tablet
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Erlocip 150 mg Tablet

Erlocip 150 mg Tablet

Erlocip 150 mg Tablet contains erlotinib 150 mg, a targeted anticancer medicine used mainly for certain types of non-small cell lung cancer and pancreatic cancer. It is an oral tablet taken as directed by the oncologist. Erlotinib works by blocking EGFR tyrosine kinase activity, which can help slow the growth of cancer cells.

BUY NOW

Category

Erlocip 150 mg Tablet is used for specific advanced or metastatic non-small cell lung cancer and, in combination with other treatment, for advanced pancreatic cancer. Erlotinib belongs to the tyrosine kinase inhibitor class and targets signals involved in cancer-cell growth and multiplication. The prescribed dose and treatment duration depend on the patient’s cancer type, treatment response, and the oncologist’s clinical plan. Regular medical follow-up is important during therapy to monitor treatment response and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 150 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer/Marketer Cipla Ltd

Product Also Known As

Erlocip 150 mg Tablet, Erlocip 150 Tablet, Erlocip Erlotinib Tablet, Erlotinib 150 mg Tablet, Erlotinib Hydrochloride Tablet, Erlotinib Lung Cancer Tablet